Oncolytics Biotech Reports Data in Colorectal Cancer Study
By Karen Roman Oncolytics Biotech Inc. (Nasdaq: ONCY) said it has new data showing the use of pelareorep in metastatic colorectal cancer has a 19.5-month median...
Eyeing an IPO: HotelPlanner Co-CEO Tim Hentschel at Nasdaq
IPO Edge hosted a fireside chat on Oct. 23 at Nasdaq MarketSite with Tim Hentschel, co-founder...
Highlights: NASDAQ Firesides in Sep, New Interviews Scheduled Oct 23
IPO Edge and CorpGov are pleased...
Highlights: NYSE Firesides in Sep, New Interviews Scheduled Oct 24
IPO Edge and CorpGov are pleased to provide video highlights from the latest firesides at...
IPO Edge’s Jannarone: How to Predict IPOs by ‘Hectocorns’ Like SpaceX, OpenAI – Schwab TV
By Karen Roman IPO Edge Editor-in-Chief John Jannarone joined an interview with Schwab Network’s Nicole Petallides on...
Tech to Support Legal Teams: LinkSquares CFO Luigi Testa, Live from NYSE
IPO Edge hosted a fireside chat on Sept. 13 from the floor of the New...
Travel & Expense Solutions: Mesh Payments CEO Oded Zehavi, Live from NYSE
IPO Edge hosted a fireside chat on Sept. 13 from the floor of the New...
IPO Preparedness and Market Prospects: ICR Capital Partner Steve Parish, Live from NYSE
IPO Edge hosted a fireside chat on Sept. 13 from the floor of the New...
